American Chemical Society - 233rd national meeting. CNS, cancer and cardiovascular targets

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)310-312
Number of pages3
JournalIDrugs
Volume10
Issue number5
StatePublished - 1 May 2007

Fingerprint

CD18 Antigens
CD11b Antigens
Piperazines
Lobeline
Vesicular Monoamine Transport Proteins
Sodium Channel Blockers
PAR-1 Receptor
Investigational Drugs
Integrin alpha4beta1
kappa Opioid Receptor
Quantitative Structure-Activity Relationship
Diterpenes
Drug Design
Drug Delivery Systems
G-Protein-Coupled Receptors
Cardiovascular Diseases
Binding Sites
Pain
Neoplasms

Cite this

@article{04a71bd82a6c4272b96cd7e4b21cf92d,
title = "American Chemical Society - 233rd national meeting. CNS, cancer and cardiovascular targets",
author = "David Rotella",
year = "2007",
month = "5",
day = "1",
language = "English",
volume = "10",
pages = "310--312",
journal = "IDrugs",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "5",

}

American Chemical Society - 233rd national meeting. CNS, cancer and cardiovascular targets. / Rotella, David.

In: IDrugs, Vol. 10, No. 5, 01.05.2007, p. 310-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - American Chemical Society - 233rd national meeting. CNS, cancer and cardiovascular targets

AU - Rotella, David

PY - 2007/5/1

Y1 - 2007/5/1

UR - http://www.scopus.com/inward/record.url?scp=34247616751&partnerID=8YFLogxK

M3 - Article

C2 - 17487780

AN - SCOPUS:34247616751

VL - 10

SP - 310

EP - 312

JO - IDrugs

JF - IDrugs

SN - 1369-7056

IS - 5

ER -